Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Drug:  valproic acid
Find trials that include:  Any drugs shown
Results 1-7 of 7 for your search:
Start Over
Valproic Acid in Treating Patients With Progressive, Non-Metastatic Prostate Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 to 85
Trial IDs: J07122, NCI-2010-02020, JHOC-J07122, JHOC-NA_00010227, NCT00670046
Valproic Acid and Radiation Therapy Followed by Maintenance Valproic Acid and Bevacizumab in Treating Young Patients With Newly Diagnosed High-Grade Gliomas
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 3 to 21
Trial IDs: H-24549, NCI-2012-00618, NCT00879437
Sorafenib Tosylate, Valproic Acid, and Sildenafil Citrate in Treating Patients with Recurrent or Progressive High-Grade Glioma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: MCC-14816, NCI-2013-00705, CTC-11-011, MCC-14816 (CTC-11-011), NCT01817751
Sunitinib Malate or Valproic Acid in Preventing Metastasis in Patients With High-Risk Uveal Melanoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 13P.377, NCI-2014-00338, 2013-047, NCT02068586
Bevacizumab and Temsirolimus Alone or in Combination with Valproic Acid or Cetuximab in Treating Patients with Advanced or Metastatic Malignancy or Other Benign Disease
Status: Active
Phase: Phase I
Type: Treatment
Age: Not specified
Trial IDs: 2012-0061, NCI-2012-00347, NCT01552434
Folate Receptor in Diagnosing Ovarian Cancer using Serum Samples from Patients with Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Age: 18 and over
Trial IDs: 2015-024, NCI-2015-01039, 1504013983, NCT02520115
Stereotactic Radiosurgery, Nivolumab, and Valproic Acid in Treating Patients with Recurrent Glioblastoma
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: CA209-378, NCI-2016-01238, 18574, NCT02648633
Start Over